S.I. No. 508/2025 - Pharmaceutical Society of Ireland (Continuing Professional Development) (Amendment) Rules 2025

Type Statutory Instrument
Publication 2025-10-31
State In force
Text As published
articles 10

This is the act as published. Later amendments are not folded into the text below: each one is a separate act in this repository and an entry in this law's history.

Reform history JSON API

Notice of the making of this Statutory Instrument was published in

“Iris Oifigiúil” of 31st October, 2025.

The Council of the Pharmaceutical Society of Ireland, in exercise of the powers conferred on the said Society by section 11 of the Pharmacy Act 2007 (No. 20 of 2007) (as adapted by the Health and Children (Alteration of Name of Department and Title of Minister) Order 2011 ( S.I. No. 219 of 2011 )), with the consent of the Minister for Health, hereby makes the following rules:-

Citation

1.

1.

(1) These Rules may be cited as the Pharmaceutical Society of Ireland (Continuing Professional Development) (Amendment) Rules 2025.

Interpretation

2.

2.

In these Rules “Principal Rules” means the Pharmaceutical Society of Ireland (Continuing Professional Development) Rules 2015 ( S.I. No. 553 of 2015 ).

Amendment of Rule 3 of Principal Rules

3.

3.

Rule 3 of the Principal Rules is amended—

“CPD review policy for pharmaceutical assistants” means the policy referred to in Rule 5(b);

“CPD review policy for pharmacists” means the policy referred to in Rule 5(a);”,

“‘Register of Pharmaceutical Assistants’, ‘Register of Pharmacists’ and ‘Register of Retail Pharmacy Businesses’ mean the relevant registers established under section 13(1)(a) of the Act;

‘registered pharmaceutical assistant’ means a person whose name is entered in the Register of Pharmaceutical Assistants;”.

Amendment of Parts 2 and 3 of Principal Rules

4.

4.

The Principal Rules are amended by substituting for Parts 2 and 3 the following:

“PART 2

DELIVERY OF CPD SYSTEM AND QUALITY ASSURANCE

Delivery of CPD system

  1. (1) For the purpose of discharging the Society’s functions under section 7(1)(d) of the Act, the Council may establish, in the form of a management arrangement, the Irish Institute of Pharmacy, to arrange for the implementation and delivery of the CPD system, as determined by the Council, and the engagement by pharmacists and pharmaceutical assistants with such system.

  2. (2) Where the Council establishes the Institute of Pharmacy in accordance with paragraph (1), the Council may, from time to time, appoint a corporate body as the Managing Body of the Institute, tasked with providing facilities and services for the Institute of Pharmacy, and the Institute shall implement and deliver the CPD system in accordance with annual work plans approved by the Council.

CPD review policies

5.

5.

For the purpose of discharging the Society’s function under section 7(1)(d) of the Act, the Council shall—

Quality assurance policy

6.

6.

For the purpose of discharging the Society’s function under section 7(1)(d) of the Act, the Council shall approve a policy of quality assurance processes for CPD activities delivered through the Institute which shall—

PART 3 CPD OBLIGATIONS OF PHARMACEUTICAL ASSISTANTS

CPD obligations of pharmaceutical assistants

7.

7.

(1) With a view to implementing learning within their professional practice, improving outcomes for patients and maintaining professional competence, pharmaceutical assistants shall undertake appropriate CPD.

Amendment of Rule 8 of Principal Rules

5.

Rule 8 of the Principal Rules is amended—

Amendment of Rule 9 of Principal Rules and insertion of Rule 9A into Principal Rules

6.

The Principal Rules are amended by substituting for Rule 9 the following Rules:

“Scope of this Part

  1. This Part applies where the CPD System in respect of pharmacists is delivered by the Institute pursuant to Rule 4.

Registration of pharmacist with Institute

9A. (1) Every person whose name is entered in the Register of Pharmacists shall also be registered with the Institute and such registration with the said Institute shall be valid for so long as the person’s name is entered in the Register of Pharmacists.

  • (2) The Council shall, on a person’s first registration as a pharmacist, or, as the case may require, on the first continued registration as a pharmacist following the commencement of these Rules, including on the re-registration or restoration of a person to the Register of Pharmacists, inform the pharmacist of his or her registration with the Institute, subsequent to which the responsibility for ongoing engagement with the Institute shall remain with the pharmacist.”.

Amendment of Rule 10 of Principal Rules

7.

Rule 10 of the Principal Rules is amended—

  • “(3) Every pharmacist shall submit prescribed extracts of their ePortfolio to the Institute for review on an annual basis or at such other intervals as may be directed by the Institute in consultation with the Council, as required under the CPD review policy for pharmacists, save where they have been exempted by the Council from such obligation, in accordance with such policy, due to extenuating circumstances.”.

Amendment of Rule 11 of Principal Rules

8.

8.

The Principal Rules are amended by substituting for Rule 11 the following:

“Supervision of CPD activity

  1. (1) Following the submission of the prescribed extracts of a pharmacist’s ePortfolio in accordance with Rule 10(3), the Institute shall issue a Certificate of Engagement by the Institute.

  2. (2) The Council may request from the Institute information in relation to compliance with Rule 10(3) and issuance of Certificates of Engagement under paragraph (1).

  3. (3) A selection of ePortfolios submitted for review pursuant to Rule 10(3) shall be reviewed by the Institute in accordance with the CPD review policy for pharmacists.

  4. (4) The review shall be carried out by the Institute having regard to the objectives and requirements set out in Rule 8 and the CPD review policy for pharmacists.

  5. (5) The outcome of the review carried out under this Rule shall be conveyed to the pharmacist concerned by the Institute within the timescales set down by the Institute and, where such review is satisfactory, the said outcome shall be issued in the form of a Certificate of Compliance with CPD Requirements.”.

Revocation of Rule 12 of Principal Rules

9.

9.

Rule 12 of the Principal Rules is revoked.

Amendment of Rule 13 of Principal Rules

10.

10.

The Principal Rules are amended by substituting for Rule 13 the following:

“Referral of information on non-compliance to Registrar

  1. The Institute shall refer to the Registrar any instance of non-compliance with these Rules by a pharmacist which has not been resolved through the Institute’s remediation policy.”.

I, Jennifer Carroll MacNeill, Minister for Health, consent to the making of the foregoing Rules.

GIVEN under my Official Seal,

23 October, 2025.

JENNIFER CARROLL MACNEILL,

Minister for Health.

GIVEN under the Official Seal of the Pharmaceutical Society of Ireland,

23 October, 2025.

DENIS O’DRISCOLL,

President.

JOANNE KISSANE,

Registrar.

EXPLANATORY NOTE

(This note is not part of the Instrument and does not purport to be a legal interpretation.)

These Rules amend the Pharmaceutical Society of Ireland (Continuing Professional Development) Rules 2015 to provide for an updated CPD system in respect of pharmacists and to introduce a CPD system for pharmaceutical assistants.

This document does not substitute the official text published in the Irish Statute Book. We accept no responsibility for any inaccuracies arising from the transcription of the original into this format.

This text is published under Irish Statute Book's own terms of reuse, not a Legalize or public-domain licence. Irish Statute Book
CC-BY 4.0 (Oireachtas Open Data PSI Licence)
Contains Irish Public Sector Information licensed under the Oireachtas (Houses of the Oireachtas) Open Data PSI Licence / Creative Commons Attribution 4.0 International, sourced from https://www.irishstatutebook.ie.